Uncategorized

UCB Investing $2B To Build Manufacturing Facility in Georgia

Published

on

The Belgian drugmaker plans to hire about 330 people at a facility that will use advanced manufacturing technologies including AI, robotics and automation to meet rising demand for key products. This will be UCB’s first biologics manufacturing facility in the U.S.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version